North American Custom Laboratories recalls
North American Custom Laboratories has 7 recalls on record with the FDA and USDA, the earliest in 2022 and the latest reported on 27 Apr 2022. The most frequent reason is sterility.
Total recalls7since 2022
Last 12 months0reported
Class I00% of total
Ongoing0latest 27 Apr 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 7 100%Class III 0 0%
Why north american custom laboratories is recalled
Product types
By year
All north american custom laboratories recalls, newest first
7 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | LL-37 2 mg/mL Injection vials recalled by North American Custom | North American Custom Laboratories | Sterility | Nationwide |
| Drug | CLASS II | BPC-157 2 mg/mL Injection vials recalled by North American Custom | North American Custom Laboratories | Sterility | Nationwide |
| Drug | CLASS II | Sermorelin Acetate 1 mg/mL Injection vials recalled | North American Custom Laboratories | Sterility | Nationwide |
| Drug | CLASS II | Ipamorelin Acetate/Sermorelin Acetate (1 mg/1 mg)/mL Injection vials recalled | North American Custom Laboratories | Sterility | Nationwide |
| Drug | CLASS II | Melanotan II 1 mg/mL Injection vials recalled by North American Custom | North American Custom Laboratories | Sterility | Nationwide |
| Drug | CLASS II | ARA-290 (Cibinetide Acetate) 6 mg/mL Injection vials recalled | North American Custom Laboratories | Sterility | Nationwide |
| Drug | CLASS II | PT-141 (Bremelanotide Acetate) 10 mg/mL Injection vials recalled | North American Custom Laboratories | Sterility | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.